Featured Article
Precision Oncology Today
Magazine
5 Key Startups Bringing Digital Pathology Into Focus
Digital pathology is driving precision medicine by turbocharging the analysis of tissue slides. Here are the five top startups turning microscopy into a data...
How Is Artificial Intelligence Changing the Clinical Trials Landscape?
There is no doubt that artificial intelligence (AI) is currently en vogue. Many AI and machine-learning applications are already being deployed in drug discovery and development. Not only can AI process, analyze, and interpret huge datasets, it can also be used for structural drug design and toxicity and efficacy predictions.
Trending on Inside Precision Medicine
Lurie Children’s Developing Optical Genome Mapping Test for Brain Tumors
Preliminary data suggests that about 30% of brain tumors show structural genomic variations.
Study Shines Light on Hereditary Back Issues
European research involving three major biobanks has identified dozens of previously unidentified regions of the genome linked with disc herniation in the lumbar spine.
Extrachromosomal DNA Spread Oncogenic Traits, Add Synthetic Lethal Targets
A trio of Nature articles reveal how extrachromosomal DNA (ecDNA) promotes cancer and how these circular molecules can be targeted therapeutically